InvestorsObserver
×
News Home

Will ATAI Life Sciences NV (ATAI) Outperform the Rest of the Stocks in the Healthcare Sector?

Wednesday, March 27, 2024 10:21 AM | InvestorsObserver Analysts

Mentioned in this article

Will ATAI Life Sciences NV (ATAI) Outperform the Rest of the Stocks in the Healthcare Sector?

ATAI Life Sciences NV (ATAI) is near the top in its sector according to InvestorsObserver. ATAI gets an overall rating of 51. That means it scores higher than 51% of stocks. ATAI Life Sciences NV gets a 87 rank in the Healthcare sector. Healthcare is number 1 out of 11 sectors.

Overall Score - 51
ATAI has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on ATAI!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 51 would rank higher than 51 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With ATAI Life Sciences NV Stock Today?

ATAI Life Sciences NV (ATAI) stock is unmoved 0% while the S&P 500 is higher by 0.36% as of 10:21 AM on Wednesday, Mar 27. ATAI is unchanged $0.00 from the previous closing price of $1.73 on volume of 450,105 shares. Over the past year the S&P 500 is up 31.50% while ATAI is higher by 30.08%. ATAI lost -$0.46 per share the over the last 12 months. Click Here to get the full Stock Report for ATAI Life Sciences NV stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App